Orange County NC Website
DocuSign Envelope ID:79C5D167-B6CA-4E59-B4AC-AA38CC1B20BD <br /> Occupational Safety and Health Admin., Labor §1910.1030 <br /> (C) Results of the source individual's vaccination is indicated for an em- <br /> testing shall be made available to the ployee, and if the employee has re- <br /> exposed employee, and the employee ceived such vaccination. <br /> shall be informed of applicable laws (ii) The healthcare professional's <br /> and regulations concerning disclosure written opinion for post-exposure eval- <br /> of the identity and infectious status of uation and follow-up shall be limited to <br /> the source individual. the following information: <br /> (iii) Collection and testing of blood (A) That the employee has been in- <br /> for HBV and HIV serological status; formed of the results of the evaluation; <br /> (A) The exposed employee's blood and <br /> shall be collected as soon as feasible (B) That the employee has been told <br /> and tested after consent is obtained. about any medical conditions resulting <br /> (B) If the employee consents to base- from exposure to blood or other poten- <br /> line blood collection, but does not give tially infectious materials which re- <br /> consent at that time for HIV serologic quire further evaluation or treatment. <br /> testing, the sample shall be preserved (iii) All other findings or diagnoses <br /> for at least 90 days. If, within 90 days of shall remain confidential and shall not <br /> the exposure incident, the employee be included in the written report. <br /> elects to have the baseline sample test- (6) Medical recordkeeping. Medical <br /> ed, such testing shall be done as soon records required by this standard shall <br /> as feasible. be maintained in accordance with para- <br /> (iv) Post-exposure prophylaxis, when graph(h)(1) of this section. <br /> medically indicated, as recommended (g) Communication of hazards to em- <br /> by the U.S. Public Health Service; ployees—(1) Labels and signs—(i) Labels. <br /> (v) Counseling; and (A) Warning labels shall be affixed to <br /> (vi)Evaluation of reported illnesses. containers of regulated waste, refrig- <br /> (4) Information Provided to the erators and freezers containing blood <br /> Healthcare Professional. (i) The em- or other potentially infectious mate- <br /> ployer shall ensure that the healthcare rial; and other containers used to <br /> professional responsible for the em- store, transport or ship blood or other <br /> ployee's Hepatitis B vaccination is pro- potentially infectious materials, ex- <br /> vided a copy of this regulation. cept as provided in paragraph <br /> (ii) The employer shall ensure that (9)(1)(i)(E), (F)and(G). <br /> the healthcare professional evaluating (B) Labels required by this section <br /> an employee after an exposure incident shall include the following legend: <br /> is provided the following information: <br /> (A)A copy of this regulation; <br /> (B) A description of the exposed em- <br /> ployee's duties as they relate to the ex- <br /> posure incident; <br /> (C) Documentation of the route(s) of 1Z <br /> 04 <br /> exposure and circumstances under <br /> which exposure occurred; �4c, V <br /> (D) Results of the source individual's <br /> blood testing, if available; and <br /> (E) All medical records relevant to <br /> the appropriate treatment of the em- <br /> ployee including vaccination status <br /> which are the employer's responsibility BIOHAZARD <br /> to maintain. <br /> (5) Healthcare Professional's Written (C) These labels shall be fluorescent <br /> Opinion. The employer shall obtain and orange or orange-red or predominantly <br /> provide the employee with a copy of so, with lettering and symbols in a con- <br /> the evaluating healthcare profes- trasting color. <br /> sional's written opinion within 15 days (D) Labels shall be affixed as close as <br /> of the completion of the evaluation. feasible to the container by string, <br /> (i)The healthcare professional's writ- wire, adhesive, or other method that <br /> ten opinion for Hepatitis B vaccination prevents their loss or unintentional re- <br /> shall be limited to whether Hepatitis B moval. <br /> 275 <br />